Abstract
Periodontal disease represents a group of oral inflammatory infections initiated by oral pathogens which exist as a complex biofilms on the tooth surface and cause destruction to tooth supporting tissues. The severity of this disease ranges from mild and reversible inflammation of the gingiva (gingivitis) to chronic destruction of connective tissues, the formation of periodontal pocket and ultimately result in loss of teeth. While human subgingival plaque harbors more than 500 bacterial species, considerable research has shown that Porphyromonas gingivalis, a Gram-negative anaerobic bacterium, is the major etiologic agent which contributes to chronic periodontitis. This black-pigmented bacterium produces a myriad of virulence factors that cause destruction to periodontal tissues either directly or indirectly by modulating the host inflammatory response. Here, this review provides an overview of P. gingivalis and how its virulence factors contribute to the pathogenesis with other microbiome consortium in oral cavity.
Introduction
Periodontal diseases are complex, multifactorial, polymicrobial infections characterized by the destruction of tooth-supporting tissues. The disease begins as acute inflammation of the gingival tissue and untreated infections can progress to formation of teeth pockets, and eventually loss of teeth. According to the World Health Organization, periodontal disease affects 10–15% of adult populations worldwide ().
Substantial data accumulated over the years has implicated the involvement of only a small proportion of bacteria, which reside in the subgingival niche, in the initiation and progression of periodontal disease. There is strong evidence that points to Porphyromonas gingivalis, a Gram-negative anaerobes, as the keystone species in the development of chronic periodontitis.
The past decades of extensive research on P. gingivalis have produced various lines of evidences on the contribution of this anaerobe to the progression of periondontal disease. These findings are important in increasing our understanding on the virulence characteristics and cellular interaction between P. gingivalis and the host, thereby elucidating potential therapeutic approaches to control periodontal disease progression.
The Oral Flora and Normal Periodontium
The oral cavity possesses a number of features which make it a distinct habitat for a menagerie of microorganisms. The surfaces in the oral cavity are continuously bathed in saliva most of the time at a narrow temperature range (34 to 36°C) and a pH close to neutrality (). With such an ideal environment, various classes of microflora are found to be distributed in various ecological niches ().
In general, the mouth harbors at least six billion bacteria which are represented by more than 700 species (; ), as well as other types of microorganisms, including fungi, mycoplasma, protozoa, and possibly even viruses (). Generally, oral bacteria can be broadly classified as Gram-positive and Gram-negative bacteria, and secondarily as either anaerobic or facultatively anaerobic according to their oxygen requirements. Some of the more frequently isolated microorganisms in human oral cavity are listed in Table 1.
Table 1
| Microbial group | Microbial genus/species |
|---|---|
| Gram-positive | |
| Aerobic or facultative | Streptococcus (S. gordonii, S. mitis, S. auralis, S. salivarius) |
| Staphylococcus (S. aureus, S. epidermidis) | |
| Enterococcus (E. faaecalis) | |
| Lactobacillus (L. casei, L. fermentum) | |
| Corynebacterium (C. matruchotii) | |
| Actinomyces (A. naeslundii, A. israelli, A. viscosus) | |
| Arachnia (A. propionica) | |
| Rothia (R. dentocariosa) | |
| Obligate anaerobes | Bacillus (B. cereus) |
| Propionibacterium (P. acnes) | |
| Peptostreptococcus (P. micros, P. anaerobius) | |
| Gram-negative | |
| Aerobic or facultative | Campylobacter (C. rectus, C. concisus, C. gracilis) |
| Actinobacillus (A. actinomycetemcomitans) | |
| Obligate anaerobes | Fusobacterium (F. nucleatum) |
| Porphyromonas (P. gingivalis) | |
| Prevotella (P. melaninogenica, P. oralis, P. intermedia) |
The predominant human oral microbiota.
Despite the diverse community of oral microbiota, the oral cavity is, nonetheless, characterized by a stable community known as the climax community. Therefore, if imbalance in the oral resident microbiota occurs, oral diseases such as caries and periodontal diseases seem to appear, leading to multiplication of potentially pathogenic microorganisms. Several studies have illustrated that a change in microbial species in the gingival sulcus from Gram-positive, facultative, fermentative microorganisms to predominantly Gram-negative, anaerobic, chemoorganotrophic, and proteolytic organisms has been highly associated with destruction of periodontal tissue ().
Periodontal Diseases
Periodontal disease generally refers to inflammatory pathologic state of the gingiva and the supporting structures of the periodontium which include gingival, alveolar bone, periodontal ligament, and cementum. They are commonly found in most human populations and result in significant morbidity, with exfoliation of the teeth in severe condition. In United States, recent epidemiological data suggests that periondontal disease affects one-half of its population over 30 years of age and is the major cause of tooth loss among adults (). According to the periodontal disease classification system proposed by the American Academy of Periodontology (AAP), periodontal diseases are generally grouped into two major categories, gingival diseases, and periodontitis, depending on whether destruction of the periodontal attachment has occurred ().
Gingival disease is defined as inflammation of the gingival tissues caused by accumulation of dental plaque and is characterized clinically by redness, swelling, and bleeding of the tissues. As the periodontal ligament and alveolar bone are not involved in this event, the attachment of the teeth is not affected (). Gingivitis can remain indefinitely for a long period and will not progress to periodontitis, unless there are perturbations in local conditions or generalized host susceptibility ().
On the other hand, periodontitis refers to the irreversible plaque-induced inflammation of the periodontal tissues leading to destruction of the periodontal ligament and alveolar bone, and migration of the epithelial ligament. Subsequently, this causes formation of a periodontal pocket, the main clinical feature of periodontitis (). This pocket is an ideal surface for bacterial colonization and the formation of subgingival plaque.
Various studies have shown that periodontitis occurs more often among patients with systemic diseases such as diabetes mellitus, AIDS, leukemia, and Down’s syndrome (; ). A growing body of evidence suggests that periodontitis may enhance the risk for several potentially deadly conditions including cardiovascular diseases (e.g., heart attack, coronary artery disease, and stroke) and diabetes (; ). According to a report by AAP in 1996, it was found that people with some forms of gum disease are almost twice as likely to suffer from coronary artery disease compared to those with healthy gum.
For many years, numerous studies have been developed to show the possible connection between periodontal disease and cardiovascular disease. Recent studies, such as the study of Nakano et al. (2006) attempted to show the direct mechanisms that link periodontal diseases to cardiovascular disease. A number of mechanisms have been proposed to explain this association including a common factor that predisposes certain individuals to hyper-inflammatory response in cardiovascular disease (). It is believed that oral pathogens could enter the bloodstream and the inflammation caused by periodontal disease increases plaque build up, which subsequently contributes to dilation of the arteries (). Figure 1 shows a simplified diagram of the potential roles that periodontal inflammation might play in the pathogenesis of cardiovascular diseases.
FIGURE 1
Streptococcus mutans, a major pathogenic agent of dental caries, was detected in unusual high frequency in both heart valve tissues and atheromatous plaque samples than any other species (Nakano et al., 2006). In fact, together with P. gingivalis, S. mutans was previously found to accelerate atherogenic plaque formation in a murine model and induce platelet aggregation, which presumably leads to thrombus formation (; ). The latest study by showed that S. mutans, Prevotella intermedia, P. gingivalis, and Treponema denticola were frequently detected in cardiac valve samples using polymerase chain reaction (PCR) method, corroborating previous findings. The high detection rate of S. mutans in dental plaque samples may suggest that the S. mutans found in the valve samples was originated from the oral cavity. However, there is a concern of the possibility of detecting DNA of dead bacteria due to the high sensitivity of real-time PCR.
On the other hand, the American Heart Association noted that neither has periodontal disease been proven to cause atherosclerotic vascular disease nor has the treatment of periodontal disease been proven to prevent atherosclerotic vascular disease (). This was supported by a report from in which there is an absence of strong correlation between periodontal condition and parameters of arteriosclerosis status in patients with coronary artery disease. This study, however, also has some limitations such as patients without coronary artery disease were excluded and biomarker samples were not collected from different regions in oral cavity to reflect local imflammatory conditions.
It was reported that periodontal disease and cardiovascular disease share common risk factors such as smoking, diabetes mellitus, aging, and obesity (). Systemic inflammatory markers were also detected from both diseases. Hence, evidence regarding a correlation between these two diseases remains a challenging study. Other common factors including lifestyle and personal hygiene also played important roles in both diseases. With much conflicting literature, there is a need to have additional long-term studies to provide a strong causative link between periodontal and heart diseases.
Besides cardiovascular disease, in vitro and animal model studies suggest that P. gingivalis can breach immune tolerance in susceptible individuals and exacerbate rheumatoid arthritis through enzymatic modification of host proteins (). Apart from that, periodontal disease has also been found to be a risk factor for pre-term low birth weight babies (). The inflammatory mediators that occur in periodontal disease have critical roles in the initiation of labor and there are plausible mechanisms that could link the two conditions (). Based on epidemiological and microbiological immunological studies, the postulated mechanisms include translocation of periodontal pathogens to the fetoplacental unit and action of a periodontal reservoir of virulence factors as inflammatory mediators. However, the relationship between adverse pregnancy outcomes and maternal antibody response to P. gingivalis awaits further investigation ().
Bacterial Etiology in Periodontal Diseases
Major advances have been made in these few decades in understanding the pathogenesis and natural history of periodontal diseases. Nevertheless, studies conducted in the 1930s to 1970s were unable to identify specific bacteria as etiological agents of periodontal diseases. As such, the “non-specific theory” was suggested, which hypothesizes that periodontal disease is due to a consortium of microorganisms rather than the importance of any bacterial species as the sole causative agents (). However, in the late 1970s and after, more specific microorganisms were isolated as etiological agents of periodontitis (; ; ).
It is now widely accepted that a myriad of bacteria and not a single microorganism, are involved in periodontal diseases. In fact, the onset of periodontal tissue inflammation is triggered by the colonization of the subgingival region by periodontal bacteria. On the tooth surfaces, for example, early or primary colonizers are mainly streptococci and actinomyces. Over time, the proportions of these Gram-positive facultatively anaerobic bacteria decrease and eventually Gram-negative anaerobes become more established, especially at the interface of the teeth and gums ().
Nonetheless, complex interactions between bacterial flora and the host defense mechanisms significantly influence the balance between bacterial aggression and host protection and thus determines whether periodontal breakdown occurs (). In light of these criteria, a number of experimental evidences have demonstrated that the primary etiological agents of periodontal diseases are generally Gram-negative rods which include Actinobacillus actinomycetemcomitans, Tannerella forsythia (previously designated Bacteroides forsythus), Prevotella, Fusobacterium, and P. gingivalis. Not one of these microbial species is capable of causing the destructive events involved in the periodontal disease progression but the etiology requires a concerted interaction of these members to establish their niches in the oral cavity (; ; ).
Porphyromonas Gingivalis and its Prevalence
Among major periodontal pathogens, P. gingivalis appears to be one of the prime etiological agents in the pathogenesis and progression of the inflammatory events of periodontal disease (). This periodontopathic bacterium was found in 85.75% of subgingival plaque samples from patients with chronic periodontitis (). This non-motile, asaccharolytic, Gram-negative bacterium is an obligately anaerobic rod which forms black-pigmented colonies on blood agar plates (Figure 2). It has an absolute requirement for iron in its growth. It was formerly named Bacteroides gingivalis prior to its reclassification as a new genus, Porphyromonas (). The name Porphyromonas comes from the Greek adjective porphyreos meaning purple and the Greek noun monas meaning unit. Hence, the word Porphyromonas means porphyrin cell as the colonies on blood agar plates turn black after 6 to 10 days due to heme accumulation ().
FIGURE 2
The major habitat of P. gingivalis is the subgingival sulcus of the human oral cavity. It relies on the fermentation of amino acids for energy production, a property required for its survival in deep periodontal pocket, where sugar availability is low (). Being an obligate anaerobe, P. gingivalis serves as the secondary colonizer of dental plaque, often adhering to primary colonizers such as Streptococcus gordonii and P. intermedia. A study by demonstrated that this asaccharolytic bacterium is associated with T. denticola and T. forsythia to form the red bacterial complex which is highly recognized in advanced periodontal lesions. Additional evidence for the presence of P. gingivalis has also came from immunological studies (; ). Virtually, all investigators agree that serum antibody levels to P. gingivalis are higher in patients diagnosed with adult periodontitis (; ).
In the past few decades, P. gingivalis strains have been classified into invasive and non-invasive strains based on their ability to form abscesses in a mouse model. It has been demonstrated that the invasive strain of P. gingivalis possesses more pathogenic activities than the non-invasive strain both in vitro and in vivo (; ).
The presence of P. gingivalis acting either alone or as a mixed infection with other oral pathogens and possibly the deficiency of certain immunological factors in the host appears to be essential for the etiology of advanced periodontitis (). The number of P. gingivalis has been shown to increase substantially in sites with periodontitis and lower or non-detectable in sites with subgingival health or plaque-associated gingivitis (). It usually resides in higher proportion in deep than in shallow periodontal pockets (). About 40–100% of adult periodontitis patients have been infected with these opportunistic bacteria.
With high frequency of P. gingivalis in adult periodontitis lesions, it is strongly hypothesized that P. gingivalis interact with other members of the host microbiota by synthesizing various pathogenic factors, leading to the progression of the disease. However, how P. gingivalis communicates with selective host cells to produce destructive biological molecules and triggers the conversion of a healthy oral tissue to a diseased state is yet to be known ().
Virulence Factors of P. gingivalis
The induction and progression of periodontal tissue destruction are complex processes involving plaque accumulation, release of bacterial substances, and host inflammatory response. P. gingivalis is known to produce a repertoire of virulence factors that could penetrate the gingivae and cause tissue destruction directly or indirectly, by induction of inflammation (). Virulence factors may be defined as the constituents or metabolites of an organism which are essential in various stages of the life cycle and cause damage to the host. The capacity of an organism colonize and evade anti-bacterial host defense mechanisms, as well as the ability to produce substances that could initiate tissue destruction, are integral features of a successful pathogen. Some of the virulence factors are given in Table 2.
Table 2
| Virulence factors | Effect on host evasion |
|---|---|
| Enzymes (hyaluronidase, chondroitin sulfatase), capsule | Decrease phagocytosis for invasion, chemotaxis inhibitors |
| Lipopolysaccharide | Bone resorption, Immunoglobulin proteases |
| Fimbriae, exopolysaccharide, outer membrane proteins | Adhesion or attachment to host outer membrane |
| Collagenase, trypsin-like protease, gelatinase | Degradation of plasma protease inhibitors, destruction of periodontal tissue |
| Aminopeptidase | Degradation of iron transport protein |
The virulence factors and host effectors produced by P. gingivalis.
In order to survive and multiply in a host, the invading pathogen needs to overcome the host external protective barriers before it could find a suitable ecological niche for colonization. Colonization of the host tissues could only happen in the presence of virulence factors such as fimbriae, capsules, lipopolysaccharide (LPS), lipoteichoic acids, haemagglutinins, gingipains, outer membrane proteins, and outer membrane vesicles (; ). The expression of virulence factors is often regulated in response to changes in the external environment of the periodontopathogen. If active in a susceptible host, these virulence factors can result in a rapid and significant destruction of periodontal tissues, bone resorption, induction of host responses by cytokine production, as well as inhibition of host protective mechanisms. However, the expression of these virulence determinants and their mechanism during various stages of periodontal disease have not been extensively investigated. To fully understand the specific function of each factor and its mechanism in pathogenesis requires inactivation of the factors coupled with biochemical evaluation and in vivo virulence testing.
Capsules
To get established in the oral cavity, microorganisms must first adhere to teeth or to mucosal surfaces (). Adherence is essential for providing resistance to the flow of saliva. Adherence is usually mediated by adhesins on the surface of bacteria and by receptors on the oral surface. Microbial adhesins are found as cell wall components or are associated with cell structures, such as capsules or fimbriae (). The chemical composition of the capsule differs between strains, mainly in their sugar composition. For instance, P. gingivalis ATCC 53977 does not contain galactose but is rich in amino sugars. P. gingivalis is found to display at least six serotypes of capsular antigens, which comprises K1–K6 ().
One of the earliest studies reported that highly encapsulated P. gingivalis strains exhibit decreased autoagglutination, lower densities and are more hydrophilic than the non-encapsulated strains (). According to , increased encapsulation is also correlated with increased resistance to phagocytosis, serum resistance, and decreased induction of polymorphonuclear leukocyte chemiluminescence. In addition, the capsule is also found to be involved in the perturbation of gingival epithelial cells. Studies by revealed that the presence and type of capsule had a significant influence on the initial adhesion of P. gingivalis to human periodontal pocket epithelial cells. However, it should be noted that the capsule may possibly interact with surface protein to facilitate attachment to the host cells. On the other hand, the level and mechanism of co-aggregation between P. gingivalis and another periodotopathogen, Fusobacterium nucleatum has been shown to be capsular dependent () as well. Another study by revealed that the virulent P. gingivalis W83 and W50 which have thicker capsules cause a decrease in the production of leukocytes than those strains which are less virulent such as strain 376. This clearly indicates that the observed difference in virulence strains is likely due to difference in capsular structure and adhesion capacity.
Studies using mouse infection models have revealed that by shielding microbial surface components, encapsulated P. gingivalis strains are more virulent than non-encapsulated strains. Non-encapsulated strains mostly cause non-invasive, localized abscesses whereas encapsulated strains cause invasive, spreading phlegmonous infections after subcutaneous inoculation of experimental animals. The non-encapsulated strains are also subjected to increased phagocytosis or are killed quickly by macrophages and dentritic cells (). On the contrary, in terms of invasion efficiency, the capsule of P. gingivalis makes it less efficient in invading gingival fibroblast compared to the non-capsular strains (). Recent findings by demonstrated that encapsulated P. gingivalis was able to modulate the host response to bacteria by reducing the synthesis of cytokines interleukin-1 (IL-1), IL-6, and IL-8 by fibroblasts. On top of its immunomodulating properties, capsule was shown to promote virulence using mouse abscess model by reducing phagocytosis and thereby increasing bacterial survival within host cells, and ultimately a long-term inflammatory response (). However, the effect of oxidative stress on expression of capsule was not taken into account as the experiments were performed under anaerobic conditions. Further validations are needed to show a more precise contribution of capsule in pathogenicity. In additional to bacterial survival, capsule may also contribute to increased survival by reducing the bactericidal effect of small antimicrobial peptide known as defensins (). This study used Drosophila melanogaster killing model to characterize the host response to P. gingivalis infection. Hence, the findings might not be very significant as Drosophila is not a natural host for P. gingivalis and host–pathogen interactions could not be studied using this organism.
In the past decade, the regulatory mechanisms in synthesis of capsular surface has been the object of great attention. It is believed that the mechanisms are quite complicated, involving posttranscriptional regulation and expression of biosynthetic machinery from multiple loci. To date, only two different regulatory mechanisms have been identified in P. gingivalis. One is a tyrosine phosphatase (Ltp1) encoded by PG1641, which controls expression of a number of genes encoding proteins involved in the synthesis of surface polysaccharides. In the ltp1 deletion mutant, the expression of K-antigen capsule was downregulated (). The second regulatory mechanism that has been identified is the DNABII protein HU β-subunit (PG0121) which likewise, caused a decrease in expression of K-antigen synthesis locus in PG0121 mutant (; ). The latest study by demonstrated that an antisense RNA molecule which is encoded within the 77 bp inverted repeat element near the 5′ end of the K-antigen capsule synthesis genes affect the expression of capsular surface in virulent P. gingivalis strain W83. Deletion of this element diminished the capsule synthesis and altered the structure of LPS (). This major findings are important in elucidating the regulatory role of secondary structure of RNA in modulating the synthesis of K-antigen capsule. However, it is not known if the antisense RNA is a genuine RNA or encodes for a signaling peptide. Furthermore, it is not known if other regulatory genes may play a role in interacting with other proteins or enzymes in capsule production.
Fimbriae
Fimbriae are thin, proteinaceous surface appendages that protrude from the outer membrane of a bacterial cell. These 3–25 μm long structures are harbored by most of the P. gingivalis strains. Research on P. gingivalis fimbriae has a long history going back to the 1980s (). Studies showed that P. gingivalis expresses two distinct fimbriae on its cell surface: one consists of a subunit protein (named FimA or fimbrillin) encoded by the fimA gene (termed long, or major fimbriae), while the other subunit Mfa protein is encoded by the mfa1 gene (termed short, minor or Mfa1 fimbriae). Even though the two fimbriae are antigenically distinct and differ in their amino acid composition, they are believed to contribute to the progression of periodontal inflammatory reactions (). Interestingly, a major fimbria-like structure was found in a P. gingivalis strain in which neither FimA nor Mfa1 fimbriae was detected. This 53 kDa novel fimbriae is another major outer membrane protein of P. gingivalis ().
Depending on the strain, the FimA protein varies in size from 40.5 to 49 kDa. Based on the amino terminal and the DNA sequences, it is classified into six types: types I–V and Ib (; ). Strains with type IV FimA such as strains W50 and W83, are poorly fimbriated. Strains 381, ATCC 33277, and HG565, on the hand, are abundantly fimbriated type I strains that have significant adhesion to host tissues. It was reported that most of the periodontal patients harbored FimA type II strains followed by type IV ().
Research on the 67-kDa minor fimbria is very much limited. The clonal diversity of minor fimbriae is not well-studied among P. gingivalis strains. Similar to FimA protein, distinct minor fimbriae molecules, FimCDE, are found in different strains. A study by demonstrated that minor fimbriae stimulated the production of interleukin-1α (IL-1α), IL-1β, IL-6, and tumor necrosis factor-α (TNF-α) by macrophages. It is highly postulated that the minor fimbria is a causative factor of alveolar bone resorption in animal models. This study, however, requires further validation as clonal diversity of minor fimbriae is unclear but it is likely to contribute to the progression of human periodontitis.
Early studies in 1990s on P. gingivalis fimbriae deficiency strains revealed the essential roles of fimbriae in the binding as well as invasion of host cells (; ). It also mediates adherence to a wide range of oral substrates and molecules including extracellular matrix proteins, oral epithelial and commensal bacteria such as streptococci and Actinomyces viscosus (). reported that fimbriae type II is capable of adhering to cellular α5β1-integrin which enables the bacteria to be easily engulfed by host phagocytes and dendritic cells and causes actin cytoskeleton rearrangement to facilitate internalization. Subsequently, this allows the intracellular bacteria to impair the host cellular function with their virulence factors (; Figure 3). It was reported that the major fimbriae is involved in the initial invasion of osteoblasts by P. gingivalis, but are not essential for the subsequent inhibition of osteoblast differentiation and mineralization ().
FIGURE 3
Many reports argue the binding of FimA residues in the fimbriae to the target molecules, but it is reported that minor components of FimCDE critically function as an adhesin (). FimA protein was not essential for the invasive capabilities of P. gingivalis outer membrane vesicles. Nevertheless, higher number of protein components associated with vesicles derived from a fimbriated strain are internalized into human gingival fibroblasts in comparison to a fimbriated strain (). In addition, P. gingivalis fimbriae act as an important virulence factor in atherosclerosis progression. It was reported that P. gingivalis infection reduced regulatory T cells (Tregs) in atherosclerotic patients. Tregs may play a crucial role in autoimmune response during this process. However, whether P. gingivalis infection is associated with Tregs dysregulation during atherosclerosis is still unknown and the prevalence of different P. gingivalis FimA genotypes during this process remains unclear ().
Meanwhile, there are various plant-derived compounds used to inhibit activity of P. gingivalis. Two of these studies were performed by on anti-inflammatory activity of quercetin, resveratrol, and its related compounds, catechin, epicatechin, orcinol, and 4-allylphenol. It was demonstrated that the natural compounds exhibited inhibitory effect on the activity of P. gingivalis fimbriae. However, it should be noted that more studies on different strains of P. gingivalis are needed to support the aforementioned hypotheses as strain variability may have different pathogenicity.
Lipopolysaccharide (LPS)
Lipopolysaccharide (LPS) is a relatively large molecule with at least 10 kDa in size. It constitues an important component of the bacterial outer membrane (). In general, the bacterial LPS consists of a distal polysaccharide (or O-antigen), a non-repeating “core” oligosaccharide and a hydrophobic domain known as lipid A (or endotoxin) (; Figure 4). Lipid A, the inner-most component, is the biological active region of LPS that could cause deregulation of the mammalian innate immune system by interacting with both toll-like receptors 2 and 4 (). It has heterogeneous acylation patterns which change according to microenvironmental conditions and affect the host immune signaling, thereby facilitating bacterial survival in the host ().
FIGURE 4
In Gram-negative bacteria, LPS plays critical roles for maintainance of the cellular and structural integrity, as well as a controlling the entry of hydrophobic molecules and toxic chemicals. In fact, the folding and insertion of outer membrane protein could not take place in the absence of LPS (). Based on its biological activity, LPS is found to be an important pathogenic factor among many periodontopathic bacteria. A number of investigations have reported the ability of this outer membrane component to activate the host inflammatory responses and disrupt bone remodeling process (; ). In clinically healthy periodontium, a normal inflammatory response is a fundamental component of the host defense system with the production of IL-1. IL-1 is believed to play a role in the pathogenesis of periodontal disease through inflammatory reactions through activation of toll-like receptor 4 (; ).
One possible role of LPS in P. gingivalis is to disrupt the innate host surveillance by interfering with distribution of leukocytes in the vicinity of bacterial colonization. In fact, P. gingivalis LPS is poorly recognized by innate host defense system compared with the LPS of other Gram-negative species (i.e., Escherichia coli) (). Other than that, the ability of gingival epithelial cells to secrete chemokine interleukin 8 (IL-8) was paralyzed, thereby activation of neutrophils, eosinophils, and basophils are affected (; ). This phenomeneon, known as chemokine paralysis, results in resistance to oxidative burst-killing by polymorphonuclear neutrophils. In the absence of an effective innate host immune defense, the number of periodontal bacteria could increase remarkably. The rise of the bacterial population at the gingival area coupled with the failure of host defense system to remove them are consistent with the observed etiology of periodontal disease. Besides inducing pro-inflammatory cytokines synthesis, P. gingivalis LPS inhibits osteoblastic differentiation and mineralisation in periodontal ligament stem cells which participate in periodontal tissue regeneration ().
In addition, a recent mice study demonstrated that P. gingivalis LPS circulates systemically in more than 50% of periodontal patients and is found to have higher level of matrix metalloproteinase. The low systemic LPS triggers an inflammatory response in the left ventricle through metalloproteinase, thereby causing cardiac dysfunction (). Apart from that, LPS also stimulates the production of thrombospondin-1, a multifunctional extracellular matrix protein secreted by human monocytic cells. Thrombospondin-1 stimulates macrophage migration and modulates host inflammatory response (). The inflammatory responses are mediated by variety of genes. One of them is plasminogen activator inhibitor type I (PAI-1) mRNA-binding protein which was reported to be upregulated in inflammatory gingiva when induced by P. gingivalis LPS (). Even though PAI-1 plays critical roles in cell migration, it requires further studies to understand the function of plasminogen activator system in cell signaling pathway.
A growing body of evidences shows that several natural compounds exhibit inhibitory effect on LPS. It was reported that alpha-mangostin caused a decrease in IL-6 and IL-8 expression in human gingival fibroblasts (). More recent finding by demonstrated the inhibitory effect of grape seed proanthocyanidin extracts on P. gingivalis LPS while reported the roles of α-tocopherol in countering the damaging effect of LPS by reducing inflammatory cytokines, increasing β-defensins, an antimicrobial peptide, and promoting gingival fibroblast growth and migration. Tormentic acid, on the other hand, was reported to inhibit LPS-induced inflammatory response in human gingival fibroblasts (). As tormentic acid is found to possess anti-inflammatory effect by inhibiting IL-6 and IL-8 production, it can be a possible therapeutic agent for periodontal disease.
In a recent study by , it was found that differences in LPS profile of P. gingivalis clinical isolates affect colony morphology and polymyxin B resistance. Unlike the healthy subjects, isolates from periodontal subjects were resistance to polymyxin B and demonstrated low aggregation ability. This resistance highly correlates with variation in LPS profiles as LPS from healthy subjects lacks of high molecular weight O-antigen moieties and anionic polysaccharide () whereas P. gingivalis isolates from periodontal subjects produce modified lipid-A molecules. However, the role of other LPS components are poorly understood and the participation of other virulence factors in response to antimicrobial compounds were not taken into consideration.
Another important point worth noting is the expression of LPS in various P. gingivalis strains, and their roles during various stages of infection still remains controversial. One of the main reasons presumably could be the use of different P. gingivalis strains that are inevitably pleiotropic with respect to other pathogenic properties. Hence, the basis for the variation of LPS in different strains has yet to be established.
Proteases
The ability of most P. gingivalis strains to secrete numerous hydrolytic, proteolytic, and lipolytic enzymes along with toxic metabolites, is one of the virulence characteristic that allows these bacteria to thrive in the oral cavity. These enzymes usually come into close proximity with the host cells. While some enzymes are found within the periplasmic space, others are transported from the outer membrane into outer membrane vesicles during growth. One of the type of enzymes, proteases, appear to be strongly implicated in periodontal disease progression. Among these proteases are trypsin-, thiol-, caseinolytic proteinases, and peptidases (; ).
There are generally two distinct families of proteases produced by P. gingivalis. One of them is the cysteine proteinase family or also known as “trypsin-like” enzyme and the other one is serine proteinase (). The “trypsin-like” enzymes cleave polypeptides at the C-terminal after arginine or lysine residue. These proteinases are commonly known as gingipains, namely gingipain R and K, that cleave after arginine and lysine, respectively. They collectively account for 85% of the extracellular proteolytic activity of P. gingivalis at the site of infection (). There are two types of gingipain R, namely RgpA and RgpB, while there is one type of gingipain K, Kgp. Gingipain R degrades extracellular matrix components, including the integrin–fibronectin-binding, cytokine, immunoglobulin and complement factors (). It is also vital for the processing and maturation of the major fimbriae (FimA) (). Both gingipain R and K have been isolated from many P. gingivalis strains grown under different conditions.
There are strong evidences that indicate P. gingivalis proteases involve directly in the colonization of the periodontal pocket, leading to destruction of supporting periodontal tissue (; ). In addition, the proteases also confer high resistance of the microorganisms to host defense mechanisms. Extensive investigations within the past decade have shown that P. gingivalis proteases are involved in the degradation of extracellular matrix proteins such as collagen, activation of the host matrix metalloproteinases, inactivation of plasma proteinase inhibitors, cleavage of cell surface receptors, and deregulation of the inflammatory (; ). They are also important additive agents on the growth of T. forsythia and A. actinomycetemcomitans in a mixed-species biofilm with P. gingivalis (; ).
Gingipain was found to degrade fibrinogen and host heme proteins which contribute to inhibition of blood coagulation and increase bleeding, thereby enhancing the availability of hemin for bacterial growth (). Hence, it may not be surprising to find high proliferation of P. gingivalis within periodontal pockets in which erythrocytes are abundant. Gingipains are also considered important in its capacity to degrade antibacterial peptides, such as neutrophil-derived α-defensins, complement factors, such as C3 and C4, T cell receptors, such as CD4 and CD8 (; ). They also reduce the expression of innate immune receptors CD14, which result in macrophage hyporesponsiveness to bacterial infection. However, whether reduced CD14 expression is linked to periodontitis induced by P. gingivalis awaits further clarification. In a recent work by , P. gingivalis and its gingipains, proactively manipulate host molecules, for instance, by interfering cross-talk between C5a receptor and toll-like receptor signaling to prevent bacterial clearance. In vitro studies have demonstrated that gingipains participate in the regulation of inflammatory mediators from various host cells, including IL-1 α, IL-1β, IL-18 (), protease-activated receptor (PAR)-2 (), or soluble triggering receptor expressed on myeloid cells (sTREM)-1 (). Nevertheless, to this extent, there is no concrete evidence to show simultaneous effect of gingipains on these inflammatory mediators in the progression of periodontitis.
Rhein, an anthraquinone from rhubarb roots, exhibits antibacterial synergistic effect with other polyphenols. It causes a downregulation of two protease genes, rgpA and kgp, which are associated with inactivation of host defense mechanisms and tissue destruction (). On the other hand, theaflavins, the main polyphenols in black tea, markedly inhibits the proteinase activities of P. gingivalis gingipains in a dose-dependent manner (). A synthetic dual protease inhibitor, termed as KYT-41, was synthesized and found to possess potent antibacterial activity against P. gingivalis. This dual inhibitor of Rgp and Kgp proteases exhibit anti-inflammatory activity, thereby is thought to be a promising agent for preventing and treating gingivitis ().
Outer Membrane Proteins
The cell envelope of Gram-negative bacteria such as Porphyromonas sp. comprises of two cell membranes, the outer membrane (OM) and the inner membrane (IM). Both layers of membranes have different composition and structure. They are separated by the periplasm containing the peptidoglycan layer. While the IM is a phospholipid bilayer with numerous integral IM proteins (), the OM is an asymmetrical bilayer which consists of phospholipids and lipopolysaccharide in the inner and outer leaflet, respectively. The bacterial cell membrane plays a role as the selective barrier that offers protection and allows the movements of various substances through OM porin proteins (). The OM proteins are generally divided into two categories, the OM lipoproteins that are anchored to the OM by an N-terminal lipid tail, and another is OM integral proteins which contain membrane-spanning regions ().
The OM is involved in most of the specific recognition processes as it is the most exposed region of a bacterial cell. As relatively few major proteins exist in the OM region, these proteins are expected to be important antigens to the host. The formation and maintenance of periodontal biofilms is postulated to be associated with the interaction among periodontal microflora which is mediated by OM proteins (). There are evidences that T helper cells of aggressive periodontitis patients activated with P. gingivalis OM proteins produced higher levels of pro-inflammatory cytokines such as IL-1β and IL-6 in comparison with healthy controls ().
Analysis of proteins extracted from the OM using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) revealed the OM consists of a diverse array of proteins ranging in size between 20 and more than 100 kDa. The most abundant OM proteins consistently identified are porins and OmpA-like proteins (). However, until recently, research on major OM proteins in P. gingivalis remains scarce due to hydrophobicity nature of the proteins. Several attempts have been made to characterize the OM proteins using different solubilization methods ().
One of the earliest studies is by is in which a 75-kDa major OM protein that exists as a high molecular weight oligomer was successfully purified. This protein was demonstrated by to stimulate activation of polyclonal B-cell and production of IL-1 from mouse peritoneal macrophages.
On the other hand, reported that a 40-kDa OM protein from P. gingivalis is an important aggregation factor on the cell surface. In this study, the antibody against the protein inhibited the aggregation activity of P. gingivalis cells toward A. viscosus, which is one of the pioneers to colonize the tooth surfaces. This 40-kDa OM protein is found in many strains of P. gingivalis, residing both at the cell surface and in extracellular vesicle. Transcutaneous immunization of mice with 40 kDa OM protein elicited an increase in IgG antibody which inhibited the coaggregation of P. gingivalis vesicles (). In recent years, in animal model studies by and , vaccination of mice with 40-kDa OM protein of P. gingivalis was demonstrated to elicit a significant reduction of alveolar bone loss.
The 40-kDa OM protein is also a hemin-binding protein (). Meanwhile, nasal immunization with 40kDa OM protein plus cholera toxin elicits protective immune response against P. gingivalis in both young and aged mice besides preventing atherosclerosis (; ). Together, the results suggest that nasal delivery of OM protein could be a potential vaccine strategy to provide protective immunity to human and hence prevention of periodontitis.
In addition, the OM protein profiles of P. gingivalis ATCC 33277 and W83 were compared, and it was found that both strains possess most OM proteins, such as RagA, RagB, and OmpA-like proteins in similar distribution pattern (). These findings, using inmmunoblotting, suggest that these OM proteins are surface-located immunoreactive antigen but cross-reaction with other P. gingivalis-related strains has to be taken into consideration.
According to , an OM protein, LptO (PG0027) was found to be essential for the O-deacylation of LPS of P. gingivalis and such structural formation is postulated to be essential to provide attachment to host cells. It also plays important role in secretion of gingipain to the cell surface. Using blue native PAGE analysis, LptO was found in up to seven different complex sizes and it interacted with another protein complex, PG0026, in secretion of C-terminal domain proteins (; ). Apart from that, a novel OM protein, coined as PG534, was found to play important roles in producing active gingipains (). The activities of gingipains R (RgpA and RgpB) and gingipain K (Kgp) in P. gingivalis with defective PG534 protein were reduced in relative to its wildtype strain.
There are also studies to attenuate the effect P. gingivalis OM proteins. For instance, studies on natural plant extracts such as polyphenols of Myrothamnus flabellifolia was shown to reduce P. gingivalis adhesion and invasion up to about 50% by interacting with bacterial OM proteins. Such anti-adhesive effect is also accompanied by cytoprotective effects which relates to cytokine secretion (). However, it has to be noted that this plant extract was only tested on OM proteins but not on other virulence components of P. gingivalis.
Conclusion
Taken together, P. gingivalis is a major etiological agent in the development of chronic periodontitis. This secondary colonizer is found to express a plethora of virulence factors involved in colonizing the subgingival plaque and modulating the immune responses of the host cells. In order to increase survival into the host, P. gingivalis is able to locally invade periondontal tissue, thereby avoiding the immune surveillance while maintaining its viability. Each virulence factor plays important roles to hamper the cell-mediated immune response in host. Nevertheless, in spite of the convincing data presented in this study, it should be cautioned that in an actual in vivo situation, the bacteria express a whole subset of virulence factors that may interact with and stimulate host cells in a different way than a single virulence factor. In addition, periodontal disease is rarely the result of single bacteria. Hence, P. gingivalis is likely to work with other oral microbiota to thrive in a harsh inflammatory condition in periodontal pocket.
To date, numerous studies have been done to elucidate the mechanism of virulence compounds secreted by P. gingivalis and the cellular interaction with the host. Improved understanding of the interaction between periodontal bacteria and host cells at the molecular and cellular level, may ultimately have relevance to the overall well-being of the host. In recent years, the use of natural compounds has gained more attention to attenuate the action of P. gingivalis. Plant-derived natural products have been widely explored as the therapeutic roles in regulating interactions between microorganisms. One of the appealing therapeutic feature is bioactive compounds from plants appear to be safe and should not cause toxicity toward human cells. However, a comprehensive toxicity studies on these compounds are still deemed necessary.
With tremendous progress in biomedical studies, we expect to eventually elucidate the possible unique mechanism of P. gingivalis and its virulence determinants. Exploration of this field will be of help in the development of effective therapies for controlling bacterial-induced connective tissue destruction. These therapeutics approaches may be important in controlling chronic P. gingivalis infections by preventing growth and colonization of P. gingivalis.
Statements
Author contributions
KH analyzed literature and wrote the paper, KS and KC edited and approved the manuscript.
Acknowledgments
This work was supported by the University of Malaya High Impact Research Grants (UM C/625/1/HIR/MOHE/CHAN/01, A-000001-50001, and UM C/625/1/HIR/MOHE/CHAN/14/1, H-50001-A000027) awarded to KC.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AasJ. A.PasterB. J.StokesL. N.OlsenI.DewhirstF. E. (2005). Defining the normal bacterial flora of the oral cavity.J. Clin. Microbiol.435721–5732. 10.1128/JCM.43.11.5721-5732.2005
2
AliR. W.VelcescuC.JivanescuM. C.LofthusB.SkaugN. (1996). Prevalence of 6 putative periodontal pathogens in subgingival plaque samples from Romanian adult periodontitis patients.J. Clin. Periodontol.23133–139. 10.1111/j.1600-051X.1996.tb00546.x
3
AliT.AbidinK. Z. (2012). Relationship of periodontal disease to pre-term low birth weight infants in a selected population–a prospective study.Community Dent. Health29100–105.
4
Al-QutubM. N.BrahamP. H.Karimi-NaserL. M.LiuX.GencoC. A.DarveauR. P. (2006). Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide.Infect. Immun.744474–4485. 10.1128/IAI.01924-05
5
AmanoA. (2007). Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis.Front. Biosci.12:3965–3974. 10.2741/2363
6
AmanoA. (2010). Bacterial adhesins to host components in periodontitis.Periodontology200012–37. 10.1111/j.1600-0757.2009.00307.x
7
AmanoA.NakagawaI.OkahashiN.HamadaN. (2004). Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis.J. Periodontal. Res.39136–142. 10.1111/j.1600-0765.2004.00719.x
8
AmanoA.TakeuchiH.FurutaN. (2010). Outer membrane vesicles function as offensive weapons in host-parasite interactions.Microbes Infect.12791–798. 10.1016/j.micinf.2010.05.008
9
AndrianE.GrenierD.RouabhiaM. (2004). In vitro models of tissue penetration and destruction by Porphyromonas gingivalis.Infect. Immun.724689–4698. 10.1128/IAI.72.8.4689-4698.2004
10
AzelmatJ.LarenteJ. F.GrenierD. (2015). The anthraquinone rhein exhibits synergistic antibacterial activity in association with metronidazole or natural compounds and attenuates virulence gene expression in Porphyromonas gingivalis.Arch. Oral Biol.60342–346. 10.1016/j.archoralbio.2014.11.006
11
BaekK. J.JiS.KimY. C.ChoiY. (2015). Association of the invasion ability of Porphyromonas gingivalis with the severity of periodontitis.Virulence6274–281. 10.1080/21505594.2014.1000764
12
BainbridgeB. W.HiranoT.GrieshaberN.DaveyM. E. (2015). Deletion of a 77-base-pair inverted repeat element alters the synthesis of surface polysaccharides in Porphyromonas gingivalis.J. Bacteriol.1971208–1220. 10.1128/JB.02589-14
13
BaoK.BelibasakisG. N.ThurnheerT.Aduse-OpokuJ.CurtisM. A.BostanciN. (2014). Role of Porphyromonas gingivalis gingipains in multi-species biofilm formation.BMC Microbiol.14:258. 10.1186/s12866-014-0258-7
14
BartoldP. M.NarayananA. S. (2006). Molecular and cell biology of healthy and diseased periodontal tissues.Periodontology200029–49. 10.1111/j.1600-0757.2005.00140.x
15
BeckJ.GarciaR.HeissG.VokonasP. S.OffenbacherS. (1996). Periodontal disease and cardiovascular disease.J. Periodontol.671123–1137. 10.1902/jop.1996.67.10.1123
16
BelibasakisG. N.BostanciN.ReddiD. (2010). Regulation of protease-activated receptor-2 expression in gingival fibroblasts and Jurkat T cells by Porphyromonas gingivalis.Cell Biol. Int.34287–292. 10.1042/CBI20090290
17
BodetC.ChandadF.GrenierD. (2006). [Pathogenic potential of Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, the red bacterial complex associated with periodontitis].Pathol.-Biol.55154–162. 10.1016/j.patbio.2006.07.045
18
BosM. P.RobertV.TommassenJ. (2007). Biogenesis of the gram-negative bacterial outer membrane.Annu. Rev. Microbiol.61191–214. 10.1146/annurev.micro.61.080706.093245
19
BosM. P.TommassenJ. (2004). Biogenesis of the gram-negative bacterial outer membrane.Curr. Opin. Microbiol.7610–616. 10.1016/j.mib.2004.10.011
20
BostanciN.BelibasakisG. N. (2012). Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen.FEMS Microbiol. Lett.3331–9. 10.1111/j.1574-6968.2012.02579.x
21
BostanciN.ThurnheerT.Aduse-OpokuJ.CurtisM. A.ZinkernagelA. S.BelibasakisG. N. (2013). Porphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains.PLoS ONE8:e75784. 10.1371/journal.pone.0075784
22
BrunnerJ.ScheresN.El IdrissiN. B.DengD. M.LaineM. L.van WinkelhoffA. J.et al (2010). The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts.BMC Microbiol.10:5. 10.1186/1471-2180-10-5
23
CaiY.Kurita-OchiaiT.KobayashiR.HashizumeT.YamamotoM. (2013). Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.J. Oral Sci.55107–114. 10.2334/josnusd.55.107
24
CasarinR. C. V.Del Peloso RibeiroÉ.MarianoF. S.NocitiF. H.Jr.CasatiM. Z.GonçalvesR. B. (2010). Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis.J. Periodont. Res.45635–642. 10.1111/j.1600-0765.2010.01278.x
25
ChenY. Y.PengB.YangQ.GlewM. D.VeithP. D.CrossK. J.et al (2011). The outer membrane protein LptO is essential for the O-deacylation of LPS and the co-ordinated secretion and attachment of A-LPS and CTD proteins in Porphyromonas gingivalis.Mol. Microbiol.791380–1401. 10.1111/j.1365-2958.2010.07530.x
26
CiX.ChenL.OuX. (2015). Grape seed proanthocyanidin extracts inhibit lipopolysaccharide of Porphyromonas gingivalis.Shanghai J. Stomatol.24433–436.
27
CurtisM.Aduse-OpokuJ.RangarajanM. (2001). Cysteine proteases of Porphyromonas gingivalis.Crit. Rev. Oral Biol. Med.12192–216. 10.1177/10454411010120030101
28
DarveauR. P.BeltonC. M.ReifeR. A.LamontR. J. (1998). Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis.Infect. Immun.661660–1665.
29
DarveauR. P.PhamT.-T. T.LemleyK.ReifeR. A.BainbridgeB. W.CoatsS. R.et al (2004). Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.Infect. Immun.725041–5051. 10.1128/IAI.72.9.5041-5051.2004
30
DattaH. K.NgW. F.WalkerJ. A.TuckS. P.VaranasiS. S. (2008). The cell biology of bone metabolism.J. Clin. Pathol.61577–587. 10.1136/jcp.2007.048868
31
de DiegoI.VeillardF.SztukowskaM. N.GuevaraT.PotempaB.PomowskiA.et al (2014). Structure and mechanism of cysteine peptidase Gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis.J. Biol. Chem.28932291–32302. 10.1074/jbc.M114.602052
32
DeLeon-PennellK. Y.de Castro BrásL. E.LindseyM. L. (2013). Circulating Porphyromonas gingivalis lipopolysaccharide resets cardiac homeostasis in mice through a matrix metalloproteinase-9-dependent mechanism.Physiol. Rep.1:e00079. 10.1002/phy2.79
33
DerradjiaA.AlanaziH.ParkH. J.DjeribiR.SemlaliA.RouabhiaM. (2015). α-tocopherol decreases interleukin-1β and -6 and increases human β-defensin-1 and -2 secretion in human gingival fibroblasts stimulated with Porphyromonas gingivalis lipopolysaccharide.J. Periodontal Res.10.1111/jre.12308[Epub ahead of print].
34
DíazL.HoareA.SotoC.BugueñoI.SilvaN.DutzanN.et al (2015). Changes in lipopolysaccharide profile of Porphyromonas gingivalis clinical isolates correlate with changes in colony morphology and polymyxin B resistance.Anaerobe3325–32. 10.1016/j.anaerobe.2015.01.009
35
DierickxK.PauwelsM.LaineM. L.Van EldereJ.CassimanJ. J.van WinkelhoffA. J.et al (2003). Adhesion of Porphyromonas gingivalis serotypes to pocket epithelium.J. Periodontol.74844–848. 10.1902/jop.2003.74.6.844
36
DornB. R.BurksJ. N.SeifertK. N.Progulske-FoxA. (2000). Invasion of endothelial and epithelial cells by strains of Porphyromonas gingivalis.FEMS Microbiol. Lett.187139–144. 10.1111/j.1574-6968.2000.tb09150.x
37
DubinG.KozielJ.PyrcK.WladykaB.PotempaJ. (2013). Bacterial proteases in disease–role in intracellular survival, evasion of coagulation/fibrinolysis innate defenses, toxicoses and viral infections.Curr. Pharm. Des.191090–1113. 10.2174/1381612811319060011
38
Eloe-FadroshE. A.RaskoD. A. (2013). The human microbiome: from symbiosis to pathogenesis.Annu. Rev. Med.64145–163. 10.1146/annurev-med-010312-133513
39
FriedewaldV. E.KornmanK. S.BeckJ. D.GencoR.GoldfineA.LibbyP.et al (2009). The american journal of cardiology and journal of periodontology editors’ consensus: periodontitis and atherosclerotic cardiovascular disease.Am. J. Cardiol.10459–68. 10.1016/j.amjcard.2009.05.002
40
FujiwaraT.MorishimaS.TakahashiI.HamadaS. (1993). Molecular cloning and sequencing of the fimbrilin gene of Porphyromonas gingivalis strains and characterization of recombinant proteins.Biochem. Biophys. Res. Commun.197241–247. 10.1006/bbrc.1993.2467
41
GencoR. J.BorgnakkeW. S. (2013). Risk factors for periodontal disease.Periodontology200059–94. 10.1111/j.1600-0757.2012.00457.x
42
GlewM. D.VeithP. D.ChenD.SeersC. A.ChenY.-Y.ReynoldsE. C. (2014). Blue native-PAGE analysis of membrane protein complexes in Porphyromonas gingivalis.J. Proteomics11072–92. 10.1016/j.jprot.2014.07.033
43
GokyuM.KobayashiH.NanbaraH.SudoT.IkedaY.SudaT.et al (2014). Thrombospondin-1 production is enhanced by Porphyromonas gingivalis lipopolysaccharide in THP-1 cells.PLoS ONE9:e115107. 10.1371/journal.pone.0115107
44
GonzalesJ.GroegerS.JohanssonA.MeyleJ. (2014). T helper cells from aggressive periodontitis patients produce higher levels of interleukin-1 beta and interleukin-6 in interaction with Porphyromonas gingivalis.Clin. Oral Investig.181835–1843. 10.1007/s00784-013-1162-5
45
HaffajeeA. D.SocranskyS. S. (1994). Microbial etiological agents of destructive periodontal diseases.Periodontology200078–111. 10.1111/j.1600-0757.1994.tb00020.x
46
HajishengallisG.AbeT.MaekawaT.HajishengallisE.LambrisJ. D. (2013). Role of complement in host–microbe homeostasis of the periodontium.Semin. Immunol. (Elsevier)2565–72. 10.1016/j.smim.2013.04.004
47
HajishengallisG.DarveauR. P.CurtisM. A. (2012). The keystone-pathogen hypothesis.Nat. Rev. Microbiol.10717–725. 10.1038/nrmicro2873
48
HajishengallisG.LamontR. J. (2014). Breaking bad: manipulation of the host response by Porphyromonas gingivalis.Eur. J. Immunol.44328–338. 10.1002/eji.201344202
49
HajishengallisG.WangM.LiangS.TriantafilouM.TriantafilouK. (2008). Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function.Proc. Natl. Acad. Sci. U.S.A.10513532–13537. 10.1073/pnas.0803852105
50
HamadaN.WatanabeK.SasakawaC.YoshikawaM.YoshimuraF.UmemotoT. (1994). Construction and characterization of a fimA mutant of Porphyromonas gingivalis.Infect. Immun.621696–1704.
51
HamediM.BelibasakisG.CruchleyA.RangarajanM.CurtisM.BostanciN. (2009). Porphyromonas gingivalis culture supernatants differentially regulate Interleukin-1β and Interleukin-18 in human monocytic cells.Cytokine4599–104. 10.1016/j.cyto.2008.11.005
52
HandleyP. S.TiplerL. S. (1986). An electron microscope survey of the surface structures and hydrophobicity of oral and non-oral species of the bacterial genus Bacteroides.Arch. Oral Biol.31325–335. 10.1016/0003-9969(86)90047-6
53
HaraguchiA.MiuraM.FujiseO.HamachiT.NishimuraF. (2014). Porphyromonas gingivalis gingipain is involved in the detachment and aggregation of Aggregatibacter actinomycetemcomitans biofilm.Mol. Oral Microbiol.29131–143. 10.1111/omi.12051
54
HayashiS.YamadaH.FukuiM.ItoH.-O.SataM. (2015). Correlation between arteriosclerosis and periodontal condition assessed by lactoferrin and α1-antitrypsin levels in gingival crevicular fluid.Int. Heart J.56639–643. 10.1536/ihj.15-218
55
HerathT. D. K.WangY.SeneviratneC. J.DarveauR. P.WangC. Y.JinL. J. (2011). Heterogeneous LPS of Porphyromonas gingivalis differentially modulate the innate immune response of human gingiva.BMC Proc.5:86. 10.1186/1753-6561-5-s1-p86
56
HerzbergM. C.MeyerM. W. (1996). Effects of oral flora on platelets: possible consequences in cardiovascular disease.J. Periodontol.671138–1142. 10.1902/jop.1996.67.10s.1138
57
HoltS. C.KesavaluL.WalkerS.GencoC. A. (1999). Virulence factors of Porphyromonas gingivalis.Periodontology2000168–238. 10.1111/j.1600-0757.1999.tb00162.x
58
IgboinC. O.TordoffK. P.MoeschbergerM. L.GriffenA. L.LeysE. J. (2011). Porphyromonas gingivalis-host interactions in a Drosophila melanogaster model.Infect. Immun.79449–458. 10.1128/IAI.00785-10
59
ImaiM.MurakamiY.NaganoK.NakamuraH.YoshimuraF. (2005). Major outer membrane proteins from Porphyromonas gingivalis: strain variation, distribution, and clinical significance in periradicular lesions.Eur. J. Oral Sci.113391–399. 10.1111/j.1600-0722.2005.00235.x
60
ImamuraT.TravisJ.PotempaJ. (2003). The biphasic virulence activities of gingipains: activation and inactivation of host proteins.Curr. Protein Pept. Sci.4443–450. 10.2174/1389203033487027
61
IrshadM.van der ReijdenW. A.CrielaardW.LaineM. L. (2012). In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule.Arch. Immunol. Ther. Exp.60469–476. 10.1007/s00005-012-0196-8
62
JainS.DarveauR. P. (2010). Contribution of Porphyromonas gingivalis lipopolysachharide to periodontitis.Periodontology200053–70. 10.1111/j.1600-0757.2009.00333.x
63
JenkinsonH. F.LamontR. J. (2006). “Oral microbial ecology,” inOral Microbiology and ImmunologyedsLamontR. J.BurneR. A.LantzM. S.LeBlancD. J. (Washington, DC: ASM Press).
64
JianC.-X.LiM.-Z.ZhengW.-Y.HeY.RenY.WuZ.-M.et al (2015). Tormentic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts via inhibition of TLR4-mediated NF-κB and MAPKs signaling pathway.Arch. Oral Biol.601327–1332. 10.1016/j.archoralbio.2015.05.005
65
KataokaS.BabaA.SudaY.TakiiR.HashimotoM.KawakuboT.et al (2014). A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy.FASEB J.283564–3578. 10.1096/fj.14-252130
66
KatoH.TaguchiY.TominagaK.UmedaM.TanakaA. (2014). Porphyromonas gingivalis LPS inhibits osteoblastic differentiation and promotes pro-inflammatory cytokine production in human periodontal ligament stem cells.Arch. Oral Biol.59167–175. 10.1016/j.archoralbio.2013.11.008
67
KatzJ.WardD.MichalekS. (1996). Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalis.Oral Microbiol. Immunol.11309–318. 10.1111/j.1399-302X.1996.tb00187.x
68
KoizumiY.Kurita-OchiaiT.OguchiS.YamamotoM. (2008). Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.Infect. Immun.762958–2965. 10.1128/IAI.01572-07
69
KomatsuT. (2014). “Oxidative stress and periodontal disease in Down Syndrome,” inStudies on Periodontal DiseaseedsEkuniD.BattinoM.TomofujiT.PutninsE. E. (Berlin: Springer) 211–223.
70
KongL.QiX.HuangS.ChenS.WuY.ZhaoL. (2015). Theaflavins inhibit pathogenic properties of P. gingivalis and MMPs production in P. gingivalis-stimulated human gingival fibroblasts.Arch. Oral Biol.6012–22. 10.1016/j.archoralbio.2014.08.019
71
KristoffersenA. K.SolliS. J.NguyenT. D.EnersenM. (2015). Association of the rgpB gingipain genotype to the major fimbriae (fimA) genotype in clinical isolates of the periodontal pathogen Porphyromonas gingivalis.J. Oral Microbiol.7:29124. 10.3402/jom.v7.29124
72
KuramitsuH. K.QiM.KangI.-C.ChenW. (2001). Role for periodontal bacteria in cardiovascular diseases.Ann. Periodontol.641–47. 10.1902/annals.2001.6.1.41
73
LaineM. L.AppelmelkB. J.van WinkelhoffA. J. (1997). Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients.J. Dent. Res.761840–1844. 10.1177/00220345970760120601
74
LeeJ. Y.SojarH. T.BediG. S.GencoR. J. (1992). Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis.Infect. Immun.601662–1670.
75
LiuC.HashizumeT.Kurita-OchiaiT.FujihashiK.YamamotoM. (2010). Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.Mol. Oral Microbiol.25178–189. 10.1111/j.2041-1014.2009.00560.x
76
LiuR.DestaT.RaptisM.DarveauR. P.GravesD. T. (2008). P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers.J. Periodontol.791241–1247. 10.1902/jop.2008.070575
77
LockhartP. B.BolgerA. F.PapapanouP. N.OsinbowaleO.TrevisanM.LevisonM. E.et al (2012). Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association.Circulation1252520–2544. 10.1161/CIR.0b013e31825719f3
78
LöhrG.BeiklerT.PodbielskiA.StandarK.RedanzS.HenselA. (2011). Polyphenols from Myrothamnus flabellifolia Welw. inhibit in vitro adhesion of Porphyromonas gingivalis and exert anti-inflammatory cytoprotective effects in KB cells.J. Clin. Periodontol.38457–469. 10.1111/j.1600-051X.2010.01654.x
79
MadianosP. N.BobetsisY. A.OffenbacherS. (2013). Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms.J. Clin. Periodontol.40S170–S180. 10.1111/jcpe.12082
80
MaebaS.OtakeS.NamikoshiJ.ShibataY.HayakawaM.AbikoY.et al (2005). Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.Vaccine232513–2521. 10.1016/j.vaccine.2004.10.036
81
MaedaK.TribbleG. D.TuckerC. M.AnayaC.ShizukuishiS.LewisJ. P.et al (2008). A Porphyromonas gingivalis tyrosine phosphatase is a multifunctional regulator of virulence attributes.Mol. Microbiol.691153–1164. 10.1111/j.1365-2958.2008.06338.x
82
MaekawaT.KraussJ. L.AbeT.JotwaniR.TriantafilouM.TriantafilouK.et al (2014). Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis.Cell Host Microbe15768–778. 10.1016/j.chom.2014.05.012
83
MahanondaR.SeymourG. J.PowellL. W.GoodM. F.HallidayJ. W. (1991). Effect of initial treatment of chronic inflammatory periodontal disease on the frequency of peripheral blood T-lymphocytes specific to periodontopathic bacteria.Oral Microbiol. Immunol.6221–227. 10.1111/j.1399-302X.1991.tb00481.x
84
MaidenM. F.CoheeP.TannerA. C. (2003). Proposal to conserve the adjectival form of the specific epithet in the reclassification of Bacteroides forsythus Tanner et al. 1986 to the genus Tannerella Sakamoto et al. 2002 as Tannerella forsythia corrig., gen. nov., comb. nov. Request for an Opinion.Int. J. Syst. Evol. Microbiol.532111–2112. 10.1099/ijs.0.02641-0
85
MantriC. K.ChenC. H.DongX.GoodwinJ. S.PratapS.ParomovV.et al (2015). Fimbriae-mediated outer membrane vesicle production and invasion of Porphyromonas gingivalis.Microbiologyopen453–65. 10.1002/mbo3.221
86
MarcotteH.LavoieM. C. (1998). Oral microbial ecology and the role of salivary immunoglobulin A.Microbiol. Mol. Biol. Rev.6271–109.
87
MareszK. J.HellvardA.SrokaA.AdamowiczK.BieleckaE.KozielJ.et al (2013). Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).PLoS Pathog.9:e1003627. 10.1371/journal.ppat.1003627
88
MehtaA. (2015). Risk factors associated with periodontal diseases and their clinical considerations.Int. J. Contemp. Dent. Med. Rev.20151–15.
89
MooreW. E.MooreL. H.RanneyR. R.SmibertR. M.BurmeisterJ. A.SchenkeinH. A. (1991). The microflora of periodontal sites showing active destructive progression.J. Clin. Periodontol.18729–739. 10.1111/j.1600-051X.1991.tb00064.x
90
MooreW. E.MooreL. V. (1994). The bacteria of periodontal diseases.Periodontology200066–77. 10.1111/j.1600-0757.1994.tb00019.x
91
MurakamiY.KawataA.ItoS.KatayamaT.FujisawaS. (2015). The radical scavenging activity and cytotoxicity of resveratrol, orcinol and 4-allylphenol and their inhibitory effects on cox-2 gene expression and Nf-κb activation in RAW264.7 cells stimulated with Porphyromonas gingivalis-fimbriae.In Vivo29341–349.
92
NaH.LimE.JeongS.RyuM.ParkM.ChungJ. (2014). Plasminogen activator inhibitor type 1 expression induced by lipopolysaccharide of Porphyromonas gingivalis in human gingival fibroblast.J. Microbiol.52154–160. 10.1007/s12275-014-3022-7
93
NaganoK.HasegawaY.YoshidaY.YoshimuraF. (2015). A major fimbrilin variant of Mfa1 fimbriae in Porphyromonas gingivalis.J. Dent. Res.941143–1148. 10.1177/0022034515588275
94
NakanoK.InabaH.NomuraR.NemotoH.TakedaM.YoshiokaH.et al (2006). Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens.J. Clin. Microbiol.443313–3317. 10.1128/JCM.00377-06
95
NikaidoH. (2003). Molecular basis of bacterial outer membrane permeability revisited.Microbiol. Mol. Biol. Rev.67593–656. 10.1128/MMBR.67.4.593-656.2003
96
NisengardR. J.NewmanM. G. (1994). Oral Microbiol Immunol.Philadelphia: W.B. Saunders Company.
97
OffenbacherS. (1996). Periodontal diseases: pathogenesis.Ann. Periodontol.1821–878. 10.1902/annals.1996.1.1.821
98
OgawaT.YagiT. (2010). Bioactive mechanism of Porphyromonas gingivalis lipid A.Periodontology200071–77. 10.1111/j.1600-0757.2009.00343.x
99
OliveiraF. A. F.ForteC. P. F.SilvaP. G.LopesC. B.MontenegroR. C.SantosÂK.et al (2015). Molecular analysis of oral bacteria in heart valve of patients with cardiovascular disease by real-time polymerase chain reaction.Medicine94:e2067. 10.1097/MD.0000000000002067
100
ParahitiyawaN. B.ScullyC.LeungW. K.YamW. C.JinL. J.SamaranayakeL. P. (2010). Exploring the oral bacterial flora: current status and future directions.Oral Dis.16136–145. 10.1111/j.1601-0825.2009.01607.x
101
PasterB. J.OlsenI.AasJ. A.DewhirstF. E. (2006). The breadth of bacterial diversity in the human periodontal pocket and other oral sites.Periodontology200080–87. 10.1111/j.1600-0757.2006.00174.x
102
PennisiE. (2005). A mouthful of microbes.Science3071899–1901. 10.1126/science.307.5717.1899
103
PetersenP. E.OgawaH. (2012). The global burden of periodontal disease: towards integration with chronic disease prevention and control.Periodontology200015–39. 10.1111/j.1600-0757.2011.00425.x
104
PotempaJ.BanbulaA.TravisJ. (2000). Role of bacterial proteinases in matrix destruction and modulation of host responses.Periodontology2000153–192. 10.1034/j.1600-0757.2000.2240108.x
105
PriyadarshiniR.CuginiC.ArndtA.ChenT.TjokroN. O.GoodmanS. D.et al (2013). The nucleoid-associated protein HUβ affects global gene expression in Porphyromonas gingivalis.Microbiology159219–229. 10.1099/mic.0.061002-0
106
RosenG.SelaM. N. (2006). Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide.FEMS Microbiol. Lett.256304–310. 10.1111/j.1574-6968.2006.00131.x
107
SaikiK.KonishiK. (2010). Identification of a novel Porphyromonas gingivalis outer membrane protein, PG534, required for the production of active gingipains.FEMS Microbiol. Lett.310168–174. 10.1111/j.1574-6968.2010.02059.x
108
SaikiK.KonishiK. (2014). Porphyromonas gingivalis C-terminal signal peptidase PG0026 and HagA interact with outer membrane protein PG27/LptO.Mol. Oral Microbiol.2932–44. 10.1111/omi.12043
109
SaitoS.HiratsukaK.HayakawaM.TakiguchiH.AbikoY. (1997). Inhibition of a Porphyromonas gingivalis colonizing factor between Actinomyces viscosus ATCC 19246 by monoclonal antibodies against recombinant 40-kDa outer-membrane protein.Gen. Pharmacol.28675–680. 10.1016/S0306-3623(96)00366-7
110
SaremiA.NelsonR. G.Tulloch-ReidM.HansonR. L.SieversM. L.TaylorG. W.et al (2005). Periodontal disease and mortality in type 2 diabetes.Diabetes Care2827–32. 10.2337/diacare.28.1.27
111
SchmidtJ.JentschH.StinguC.-S.SackU. (2014). General immune status and oral microbiology in patients with different forms of periodontitis and healthy control subjects.PLoS ONE9:e109187. 10.1371/journal.pone.0109187
112
ShahH. N.CollinsM. D. (1988). Proposal for reclassification of Bacteroides asaccharolyticus, Bacteroides gingivalis, and Bacteroides endodontalis in a new genus, Porphyromonas.Int. J. Sys. Bacteriol.38128–131. 10.1099/00207713-38-1-128
113
SharmaA.SojarH. T.LeeJ. Y.GencoR. J. (1993). Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics.Infect. Immun.613570–3573.
114
ShibataY.HiratsukaK.HayakawaM.ShirozaT.TakiguchiH.NagatsukaY.et al (2003). A 35-kDa co-aggregation factor is a hemin binding protein in Porphyromonas gingivalis.Biochem. Biophys. Res. Commun.300351–356. 10.1016/S0006-291X(02)02826-7
115
SilhavyT. J.KahneD.WalkerS. (2010). The bacterial cell envelope.Cold Spring Harb. Perspect. Biol.2:a000414. 10.1101/cshperspect.a000414
116
SinghA.WyantT.Anaya-BergmanC.Aduse-OpokuJ.BrunnerJ.LaineM. L.et al (2011). The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence.Infect. Immun.794533–4542. 10.1128/IAI.05016-11
117
SlotsJ.BragdL.WikstromM.DahlenG. (1986). The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults.J. Clin. Periodontol.13570–577. 10.1111/j.1600-051X.1986.tb00849.x
118
SrokaA.SztukowskaM.PotempaJ.TravisJ.GencoC. A. (2001). Degradation of host heme proteins by lysine- and arginine-specific cysteine proteinases (Gingipains) of Porphyromonas gingivalis.J. Bacteriol.1835609–5616. 10.1128/JB.183.19.5609-5616.2001
119
TannerA. C.HafferC.BratthallG. T.ViscontiR. A.SocranskyS. S. (1979). A study of the bacteria associated with advancing periodontitis in man.J. Clin. Periodontol.6278–307. 10.1111/j.1600-051X.1979.tb01931.x
120
TheiladeE. (1986). The non-specific theory in microbial etiology of inflammatory periodontal diseases.J. Clin. Periodontol.13905–911. 10.1111/j.1600-051X.1986.tb01425.x
121
TheiladeE. (1990). Factors Controlling the Microflora of the Healthy Human Mouth.Boca Raton, FL: CRC Press.
122
TjokroN. O.RoccoC. J.PriyadarshiniR.DaveyM. E.GoodmanS. D. (2014). A biochemical analysis of the interaction of Porphyromonas gingivalis HU PG0121 protein with DNA.PLoS ONE9:e93266. 10.1371/journal.pone.0093266
123
TravisJ.PikeR.ImamuraT.PotempaJ. (1997). Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis.J. Periodontal. Res.32120–125. 10.1111/j.1600-0765.1997.tb01392.x
124
Van SteenbergenT. J.DelemarreF. G.NamavarF.De GraaffJ. (1987). Differences in virulence within the species Bacteroides gingivalis.Antonie Van Leeuwenhoek53233–244. 10.1007/BF00393930
125
WatanabeK.YamajiY.UmemotoT. (1992). Correlation between cell-adherent activity and surface structure in Porphyromonas gingivalis.Oral Microbiol. Immunol.7357–363. 10.1111/j.1399-302X.1992.tb00636.x
126
WiebeC. B.PutninsE. E. (2000). The periodontal disease classification system of the American Academy of Periodontology–an update.J. Can. Dent. Assoc.66594–597.
127
WilliamsC. E.DavenportE. S.SterneJ. A.SivapathasundaramV.FearneJ. M.CurtisM. A. (2000). Mechanisms of risk in preterm low-birthweight infants.Periodontology2000142–150. 10.1034/j.1600-0757.2000.2230115.x
128
WilliamsR. O.FeldmannM.MainiR. N. (1992). Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.Proc. Natl. Acad. Sci. U.S.A.899784–9788. 10.1073/pnas.89.20.9784
129
YangJ.WuJ.LiuY.HuangJ.LuZ.XieL.et al (2014). Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerosis patients.PLoS ONE9:e86599. 10.1371/journal.pone.0086599
130
YiemwattanaI.KaomongkolgitR. (2015). Alpha-mangostin suppresses IL-6 and IL-8 expression in P. gingivalis LPS-stimulated human gingival fibroblasts.Odontology103348–355. 10.1007/s10266-014-0160-7
131
YoshimuraA.HaraY.KanekoT.KatoI. (1997). Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria.J. Periodontal Res.32279–286. 10.1111/j.1600-0765.1997.tb00535.x
132
YoshimuraF.MurakamiY.NishikawaK.HasegawaY.KawaminamiS. (2009). Surface components of Porphyromonas gingivalis.J. Periodontal Res.441–12. 10.1111/j.1600-0765.2008.01135.x
133
YoshimuraF.WatanabeK.TakasawaT.KawanamiM.KatoH. (1989). Purification and properties of a 75-kilodalton major protein, an immunodominant surface antigen, from the oral anaerobe Bacteroides gingivalis.Infect. Immun.573646–3652.
134
ZenobiaC.HajishengallisG. (2015). Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis.Virulence6236–243. 10.1080/21505594.2014.999567
135
ZhangT.HashizumeT.Kurita-OchiaiT.YamamotoM. (2009). Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.Biochem. Biophys. Res. Commun.390937–941. 10.1016/j.bbrc.2009.10.081
136
ZhangW.JuJ.RigneyT.TribbleG. D. (2011). Fimbriae of Porphyromonas gingivalis are important for initial invasion of osteoblasts, but not for inhibition f their differentiation and mineralization.J. Periodontol.82909–916. 10.1902/jop.2010.100501
Summary
Keywords
Porphyromonas gingivalis, oral pathogen, periodontal disease, gingivitis, virulence factors, inflammatory response
Citation
How KY, Song KP and Chan KG (2016) Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front. Microbiol. 7:53. doi: 10.3389/fmicb.2016.00053
Received
31 October 2015
Accepted
12 January 2016
Published
09 February 2016
Volume
7 - 2016
Edited by
Laurel L. Lenz, University of Colorado School of Medicine, USA
Reviewed by
Paul Fisch, University Freiburg Medical Center, Germany; Charles C. Caldwell, University of Cincinnati, USA
Updates
Copyright
© 2016 How, Song and Chan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kah Yan How, hkyan@um.edu.my
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.